Diabetic patients are known to have an independent risk of
cardiomyopathy.
Hyperglycemia leads to upregulation of
reactive oxygen species (ROS) that may contribute to
diabetic cardiomyopathy. Thus, agents that suppress
glucose-induced intracellular ROS levels can have therapeutic potential against
diabetic cardiomyopathy. Syzygium cumini is well known for its anti-diabetic potential, but its cardioprotective properties have not been evaluated yet. The aim of the present study is to analyze cardioprotective properties of methanolic seed extract (MSE) of S. cumini in diabetic in vitro conditions. ROS scavenging activity of MSE was studied in
glucose-stressed H9C2 cardiac myoblasts after optimizing the safe dose of
glucose and MSE by 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium
bromide. 2',7'-dichlorfluorescein diacetate staining and Fluorescence-activated cell sorting analysis confirmed the suppression of ROS production by MSE in
glucose-induced cells. The intracellular NO and H2O2 radical-scavenging activity of MSE was found to be significantly high in
glucose-induced cells. Exposure of
glucose-stressed H9C2 cells to MSE showed decline in the activity of
catalase and
superoxide dismutase enzymes and
collagen content.
4',6-diamidino-2-phenylindole,
propidium iodide and 10-N-nonyl-3,6-bis (dimethylamino)
acridine staining revealed that MSE protects myocardial cells from
glucose-induced stress. Taken together, our findings revealed that the well-known anti-diabetic S. cumini can also protect the cardiac cells from
glucose-induced stress.